| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 77 Employees | 29 Dec 2025 Last Dividend | 26 May 2025 Last Split | - IPO Date |
Wonbiogen Co., Ltd., established in 2006, has carved a niche in the medical equipment industry within South Korea. With its headquarters in Gumi, South Korea, this company focuses on the development and sale of an extensive range of medical supplies, specializing in medical appliances and offering OEM services. Its commitment to innovation and quality has positioned Wonbiogen as a key player in the medical equipment sector, catering to diverse healthcare needs.
Wonbiogen offers a broad spectrum of medical supplies essential for healthcare facilities. These supplies encompass a variety of products used on a daily basis in hospitals and clinics, ensuring quality care and safety for patients.
The company’s range of medical appliances includes advanced devices designed for diagnostic, therapeutic, and surgical procedures. These high-tech appliances are pivotal in enhancing patient care and outcomes, embodying Wonbiogen's dedication to medical innovation.
Providing OEM (Original Equipment Manufacturer) products, Wonbiogen collaborates with other businesses to produce items that are then marketed by another company. This service allows for a broad distribution of their technologically advanced medical products under various brand names, expanding their reach in the healthcare market.
Specializing in wound care, Wonbiogen offers dressing materials specifically designed for use in wet environments. These products are crucial for the effective management and healing of wounds, ensuring that they remain clean and protected from infection.